Publications scientifiques

Une forte valorisation scientifique de nos études attestée par nos publications

Characteristics of severe non-eosinophilic asthma: analysis of data from 1075 patients included in the FASE-CPHG study

Portel L, Fabry-Vendrand C, Texier N, Schwartz D, Capdepon A, Thabut G, Debrieuve D.

Journal of Asthma and Allergy. 2023;16:9-21

Bénéfices associés à une prise en charge par autogreffe de cellules souches chez des patients atteints de myélome multiple, nouvellement diagnostiqués, à 65 ans et au-delà : données en vie réelle, cohorte EMMY

A. Perrot, O. Decaux, A. Farge, D. Caillot, B. Royer, K. Belhadj, L. Frenzel, C. Sonntag, B. Slama, E. Bourgeois, JR. Eveillard, L. Voillat, O. Luycx, P. Moreau, GM. Pica, R. Garlantezec, R. Germain, N. Texier, C. Deal, C. Hulin

41 ème Congrès de la société française d’hématologie, 2022, Paris. Communication orale

What is the benefit of autologous stem cell transplantation in multiple myeloma beyond the age of 65? Inputs from real-world data in the EmmY cohort

A. Perrot, O. Decaux, B. Royer, D. Caillot, K. Belhadj, A. Farge, L. Frenzel, C. Sonntag, B. Slama, E. Bourgeois-Petit, P. Moreau, L. Voillat, O. Luycx, L. Benboubker, G.M. Pica, F. Maloisel, J.R. Eveillard, C. Algrin, A. Schmitt, R. Garlantezec, N. Texier, R. Germain, M. Willaime, C. Hulin

American Society of Hematology, 2022. Abstract, Poster

Retreatment of patients with anti CD38-based combinations in multiple myeloma in real-life: results from the EmmY cohort study

C. Hulin, A. Perrot, M. Macro, A. Vekhoff, X. Leleu, L. Karlin, S. Manier, L. Vincent, A. El Yamani, W. Abarah, R. Kaphan, C. Zarnitsky, D. Re, L. Christophe, O. Fitoussi, N. Texier, R. Germain, M. Willaime, O. Decaux

American Society of Hematology, 2022. Abstract, Poster

Riociguat real-world use in patients with chronic thromboembolic pulmonary hypertension: a retrospective, observational cohort study in France

Lamia B, Dallongeville J, Bensimon L, Hakme A, Bénard N, Lévy-Bachelot L, Pouriel M, Sitbon O.

Respiratory Medicine and Research, 2022, p. 100987

Les solutions numériques en santé, quelles valeurs apportées, quels mécanismes de financement et quelles évaluations ?

Charle-Maachi C, Moreau-Gaudry A, Sainati D, Camus D, Adenot I, Barthelemy CE, de Chalus T, Debroucker F, Denis F, Gourio C, Habran E, Kamal N, Le Douarin YM, Rosier A, Schuck S, Thébaut JF, Trancart A, Vercamer V.

Therapie. 2022 Jan-Feb;77(1):117-132

Contribution of perceived loneliness to suicidal thoughts among French university students during the COVID-19 pandemic

Macalli M, Kinouani S, Texier N, Schück S, Tzourio C.

Sci Rep. 2022 Oct 7;12(1):16833

Measuring Digital Vaccine Literacy: Development and Psychometric Assessment of the Digital Vaccine Literacy Scale

Montagni I, Pouymayou A, Pereira E, Tzourio C, Schück S, Texier N, González-Caballero JL; CONFINS Group.

J Med Internet Res. 2022 Dec 14;24(12)

Who is hesitant about Covid-19 vaccines? The profiling of participants in a French online cohort

Montagni I, Ouazzani-Touhami K, Pouymayou A, Pereira E, Texier N, Schück S, Tzourio C; CONFINS group.

Rev Epidemiol Sante Publique. 2022 Jun;70(3):123-131

RD vs VRD : quelle prise en charge en première ligne, en vie réelle, pour les patients atteints de myélome multiple non éligibles à une autogreffe de cellules souches dans la cohorte EMMY ?

O. Decaux, L. Frenzel, B. Royer, K. Belhadj, A. Perrot, D. Caillot, X. Leleu, A. Farge, A. Vekhoff, S. Schulmann, R. Garlantezec, N. Texier, M. Willaime, C. Nobili Escriva, C. Boccaccio, C. Hulin

41 ème Congrès de la société française d’hématologie, 2021, Paris. Communication orale

RD Vs. VRD: What Is the First-Line, Real-Life Management of Multiple Myeloma Patients Ineligible for Stem Cell Auto Transplantation in the Emmy Cohort?

O. Decaux, A. Perrot, L. Frenzel, B. Royer, C. Araujo, K. Belhadj, P. Moreau, D. Caillot, X. Leleu, A. Farge, A. Vekhoff, S. Schulmann, J. Fontan, F. Orsini, L. Sanhes, V. Richez, A. Jaccard, R. Garlantezec, N. Texier, R. Germain, C. Boccaccio, C. Hulin

American Society of Hematology, 2021. Abstract, Poster

Real-Life Survival Data after Triple-Exposure to Proteasome Inhibitors (PI), Immunomodulators (IMID) and Anti-CD38 in Multiple Myeloma Patients in the Emmy Cohort

A. Perrot, C. Hulin, M. Macro, L. Frenzel, C. Araujo, P. Moreau, B. Royer, K. Belhadj, D. Caillot, X. Leleu, A. Vekhoff, S. Schulmann, S. Manier, L. Karlin, L. Vincent, S. Rigaudeau, D. Chaoui, R. Garlantezec, N. Texier, M. Willaime, C. Boccaccio, O. Decaux

American Society of Hematology, 2021. Abstract, Poster

Therapeutic management of multiple myeloma and healthcare resource assessment by matching the EMMY Cohort to the data of the National Health Data System (SNDS) in France

O. Decaux, L. Frenzel, B. Royer, K. Belhadj, A. Perrot, D. Caillot, X. Leleu, A. Farge, A. Vekhoff, S. Schulmann, R. Garlantezec, N. Texier, M. Willaime, C. Nobili Escriva, C. Boccaccio, C. Hulin

ISPOR, 2021, Paris. Abstract, Poster

Mental health condition of college students compared to non-students during COVID-19 lockdown: the CONFINS study

Arsandaux J, Montagni I, Macalli M, Texier N, Pouriel M, Germain R, Mebarki A, Kinouani S, Tournier M, Schück S, Tzourio C.

BMJ Open. 2021 Aug 19;11(8):e053231

Acceptance of a Covid-19 vaccine is associated with ability to detect fake news and health literacy

Montagni I, Ouazzani-Touhami K, Mebarki A, Texier N, Schück S, Tzourio C; CONFINS group.

J Public Health (Oxf). 2021 Mar 9:fdab028